Evidence map›Paper›PMID 22750295›Full record

ArticlePharmacology, biochemistry, and behavior2012

Post-conditioning propranolol disrupts cocaine sensitization.

Rick E Bernardi, K Matthew Lattal

Abstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rick E BernardiOregon Health & Science University, Department of Behavioral Neuroscience, L470, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, United States. rick.bernardi@zi-mannheim.de
K Matthew Lattal
Oregon Health & Science University · US

Funding

BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
Behavioral and Epigenetic Mechanisms in Extinction of Cocaine-Induced MemoriesR01DA025922 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI LATTAL, K MATTHEW, WOOD, MARCELO ANDRES · 2008 to 2018
$5.1M
Amygdala D1 Receptor Modulation of Cocaine-Mediated MemoriesF31DA022844 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BERNARDI, RICK E · 2007 to 2008
$57k
NIDA NIH HHS F31 DA022844NIDA NIH HHS R01 DA025922NIDA NIH HHS T32 DA007262
6 · The paper itself

Abstract

Antagonists of β-adrenergic receptors (β-ARs) have previously been demonstrated to impair long-term memory in a variety of animal behavioral paradigms. Surprisingly little is known about the ability of β-ARs to modulate initial memory formation in drug conditioning paradigms. The current study examined whether the post-training administration of the β-AR antagonist, propranolol, would disrupt single-trial cocaine-induced sensitization. Rats received 10 mg/kg propranolol immediately following a 30-min cocaine or vehicle exposure in a conditioning context and were later tested for their locomotor response to a cocaine challenge. Rats that received propranolol following cocaine conditioning showed an impairment of locomotor sensitization during testing. However, this effect was only seen in animals with an initial sensitivity to the locomotor effects of cocaine. Rats that failed to show a locomotor response to cocaine during conditioning were not affected by propranolol. We discuss the implications of these findings as they relate to drug conditioning and memory consolidation studies.

Indexed as

Adrenergic beta-AntagonistsAnimalsCocaineMalePropranololRatsRats, Sprague-DawleyAdrenergic beta-AntagonistsCocainePropranolol

Identifiers

PMID22750295
PMCPMC3423590
OpenAlexW2065912483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.